Bioinformatics Tools and Machine Learning Methods for Biomarker Discovery
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Radiobiology and Nuclear Medicine".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 387
Special Issue Editors
Interests: machine learning; deep learning; data visualization; health informatics; drug discovery; natural language processing; intelligent systems
Special Issues, Collections and Topics in MDPI journals
Interests: machine learning; data science; deep learning; biomedical image analysis; health informatics; bioinformatics; drug discovery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to compile cutting-edge research and advancements in bioinformatics tools and machine learning methods specifically tailored for the discovery and validation of biomarkers in various diseases and health conditions. Biomarkers play a pivotal role in disease diagnosis, prognosis, treatment selection, and monitoring, and this Special Issue seeks to spotlight the innovative methodologies and computational approaches driving biomarker discovery. This Special Issue welcomes diverse contributions from researchers and experts across bioinformatics, computational biology, health informatics, and related domains to share their original research, methodologies, reviews, and perspectives on themes including machine learning in biomarker discovery, multi-omics integration, NGS data analysis, single-cell omics, the clinical validation of biomarkers, and addressing challenges and future directions in biomarker discovery.
Dr. Trang Do
Dr. Binh P. Nguyen
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioinformatics
- machine learning
- deep learning
- biomarkers
- multi-omics
- NGS
- single-cell
- gene expression
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.